Analysts expect AngioDynamics to post earnings of ($0.13) per share and revenue of $72.6920 million for the quarter. State of Wyoming purchased a new stake in shares of AngioDynamics in the second quarter worth about $31,000. Massar Capital Management LP purchased a new stake in shares of AngioDynamics in the second quarter worth about $278,000. Finally, Engineers Gate Manager LP purchased a new stake in shares of AngioDynamics in the second quarter worth about $392,000. Wall Street Zen upgraded AngioDynamics from a “hold” rating to a “buy” rating in a research note on Saturday, August 16th.